Trademark: 88903727
Status Date
Tuesday, March 2, 2021
Filing Date
Wednesday, May 6, 2020
Published for Opposition
Tuesday, July 21, 2020
Abandoned Date
Tuesday, March 2, 2021
5 Pharmaceutical preparations and substances for use in the treatment of hematological, autoimmune, immunological and inflammatory related diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure
Mar 2, 2021
Abandonment Notice E-Mailed - Inter Partes Decision
Mar 2, 2021
Abandonment - After Inter Partes Decision
Mar 2, 2021
Opposition Terminated No. 999999
Mar 2, 2021
Opposition Dismissed No. 999999
Jan 11, 2021
Opposition Instituted No. 999999
Aug 6, 2020
Extension Of Time To Oppose Received
Jul 21, 2020
Official Gazette Publication Confirmation E-Mailed
Jul 21, 2020
Published For Opposition
Jul 1, 2020
Notification Of Notice Of Publication E-Mailed
Jun 15, 2020
Approved For Pub - Principal Register
May 29, 2020
Examiner's Amendment Entered
May 29, 2020
Notification Of Examiners Amendment E-Mailed
May 29, 2020
Examiners Amendment E-Mailed
May 29, 2020
Examiners Amendment -Written
May 25, 2020
Assigned To Examiner
May 19, 2020
New Application Office Supplied Data Entered In Tram
May 9, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
